J
James M. Sanders
Researcher at University of Texas Southwestern Medical Center
Publications - 19
Citations - 2348
James M. Sanders is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 16 publications receiving 1843 citations. Previous affiliations of James M. Sanders include JPS Health Network & John Peter Smith Hospital.
Papers
More filters
Journal ArticleDOI
Necrotizing Soft Tissue Infections: A Focused Review of Pathophysiology, Diagnosis, Operative Management, Antimicrobial Therapy, and Pediatrics
Jeffrey M. Tessier,James M. Sanders,Massimo Sartelli,Jan Ulrych,Belinda De Simone,Julia Grabowski,Sara Buckman,Therese M. Duane +7 more
TL;DR: Although there are some additional treatment strategies available, surgical debridement and antimicrobial therapy are central to the successful eradication of the disease process.
Journal ArticleDOI
Does Isolation of Enterococcus Affect Outcomes in Intra-Abdominal Infections?
James M. Sanders,Jeffrey M. Tessier,Robert G. Sawyer,E. P. Dellinger,Preston R. Miller,Nicholas Namias,Michael West,Charles H. Cook,Patrick J. O'Neill,Lena M. Napolitano,Rishi Rattan,Joseph Cuschieri,Jeffrey A. Claridge,Chris A. Guidry,Reza Askari,Kaysie L. Banton,Ori D. Rotstein,Billy J. Moore,Therese M. Duane +18 more
TL;DR: Enterococcus was not a more common pathogen in health-care-associated IAIs and was not an independent risk factor for the composite outcome.
Journal ArticleDOI
Tedizolid vs Linezolid for the Treatment of Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients.
TL;DR: A single-center retrospective cohort study of adult SOT recipients receiving linezolid or tedizolid for an NTM infection from January 1, 2010, to August 31, 2019 was conducted in this paper.
Journal ArticleDOI
Age and Its Impact on Outcomes with Intra-Abdominal Infection.
Drew Farmer,Drew Farmer,Jeffrey M. Tessier,James M. Sanders,Robert G. Sawyer,Ori D. Rotstein,E. P. Dellinger,Pamela A. Lipsett,Joseph Cuschieri,Preston R. Miller,Charles H. Cook,Christopher A. Guidry,Reza Askari,Billy J. Moore,Therese M. Duane +14 more
TL;DR: It is suggested that advanced age itself does not play a significant role in predicting these adverse outcomes for cIAIs and does not necessitate an altered treatment tactic.
Journal ArticleDOI
Inclusion of Vancomycin as Part of Broad-Spectrum Coverage Does Not Improve Outcomes in Patients with Intra-Abdominal Infections: A Post Hoc Analysis
James M. Sanders,Jeffrey M. Tessier,Robert G. Sawyer,Pamela A. Lipsett,Preston R. Miller,Nicholas Namias,Patrick J. O'Neill,E. P. Dellinger,Raul Coimbra,Chris A. Guidry,Joseph Cuschieri,Kaysie L. Banton,Charles H. Cook,Billy J. Moore,Therese M. Duane +14 more
TL;DR: This post hoc analysis reveals that addition of vancomycin occurred in nearly one third of patients and more often in sicker patients, suggesting limited utility for adding vancomYcin to cIAI treatment regimens.